Prognostic value of Ca 125 levels during primary therapy

Anticancer Research

Volumn 27, Issue 4 A, 2007, Pages 1837-1839

  Markmann, Susanne ^a   Gerber, Bernd ^a   Briese, Volker ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Ovarian cancer; Prognostic factor; Tumor marker

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGED; CANCER SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; GERMANY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CA-125 ANTIGEN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 34250767630     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (8)

1. Bridgewater JA, Nelstrop AE and Rustin GJS: Comparison of standard and CA-125 response criteria in patients with epithelial ovarian cancer treated with platinum or paclitaxel. J Clin Oncol 17: 501-508, 1999.
2. Vaidya AP and Curtin JP: The follow-up of ovarian cancer. Semin Oncol 30: 401-412, 2003.
3. Fateh-Moghadam A (ed.), Stieber P and Seidel D: Tumormarker und ihr sinnvoller Einsatz. -2. Aufl. Marloffstein-Rathsberg: Hartmann, 1993.
4. Rustin GJS, Quinn M, Thigpen T, du Bois A, Pujade-Lauraine E, Jakobsen A, Eisenhauer E, Sagae S, Greven K, Vergote I, Cervantes A and Vermorken J: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer). J Nat Cancer Inst 96: 487-488, 2004.
5. Nielsen HA: Effect of Topotecan on serum Ca-125 in patients with advanced epithelial ovarian cancer. Gynecol Oncol 77: 383-388, 2000.
6. Paul A: Therapieergebnisse des Ovarialkarzinoms an der Universitäts-Frauenklinik Rostock von 1969 bis 1991 unter besonderer Berücksichtigung der postoperativen Chemotherapie. Rostock, Uni. Diss., 1997.
7. Scully RE and Sobin LH: Histological typing of ovarian tumours/World Health Organization. 2nd ed. International Histological Classification of Tumours, Vol. 9. Berlin: Springer, 1999.
8. Gatta G, Lasota MB, Verdecchia A and the EUROCARE Working Group: Survival of European women with gynaecological tumours during the period 1978-1989. Eur J Cancer 34: 2218-2225, 1998.